Tizanidine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Tizanidine Hydrochloride
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Contact Supplier

Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

Contact Supplier

Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

China

Contact Supplier

Tizanidine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 13 USDMF, 1 CEP/COS, 6 JDMF, 5 EU WC, 3 KDMF, 8 NDC API, 20 Listed Suppliers, $ API Reference Price

38 API Suppliers
13 USDMF
1 CEP/COS
6 JDMF
5 EU WC
3 KDMF
8 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

115 FDF Dossiers, 75 FDA Orange Book, 13 Europe, 2 Canada, 25 Listed Dossiers

115 FDF Dossiers
75 FDA Orange Book
13 Europe
2 Canada
25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 2MG BASE, CAPSULE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 6MG BASE

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 4MG BASE
CAPSULE;ORAL - EQ 2MG BASE
CAPSULE;ORAL - EQ 4MG BASE
CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 4 SPI Pharma, 10 DKSH, 4 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 23 Direct Compression, 22 Controlled & Modified Release, 21 Thickeners and Stabilizers, 20 Granulation, 17 Disintegrants & Superdisintegrants, 13 Taste Masking, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 9 Lubricants & Glidants, 9 Empty Capsules, 6 Chewable & Orodispersible Aids, 5 Topical, 5 Rheology Modifiers, 5 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Solubilizers, 3 Parenteral, 1 Surfactant & Foaming Agents

57 Fillers, Diluents & Binders
49 Coating Systems & Additives
23 Direct Compression
22 Controlled & Modified Release
21 Thickeners and Stabilizers
20 Granulation
17 Disintegrants & Superdisintegrants
13 Taste Masking
11 Film Formers & Plasticizers
11 Co-Processed Excipients
9 Lubricants & Glidants
9 Empty Capsules
6 Chewable & Orodispersible Aids
5 Topical
5 Rheology Modifiers
5 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Solubilizers
3 Parenteral
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

1 Data Compilation #PharmaFlow
24 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 19 Regulatory FDF Prices

2 US Medicaid Prescriptions
19 Regulatory FDF Prices

MARKET PLACE

9 APIs, 2 FDF Dossiers

9 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 723 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2FIDELITY BIOPHARMA

filter Patent Number Reset all filters

2 All

01 112042484

02 112263158

API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22042-05-07

Product Main Page

01

FIDELITY BIOPHARMA

TIZANIDINE HYDROCHLORIDE

IMCAS Asia

Not Confirmed

FIDELITY BIOPHARMA

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2042-05-07

TIZANIDINE HYDROCHLORIDE

US Patent Number : 12263158

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216190

Patent Use Code : U-2779

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-05-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

FIDELITY BIOPHARMA

TIZANIDINE HYDROCHLORIDE

IMCAS Asia

Not Confirmed

FIDELITY BIOPHARMA

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2042-05-07

TIZANIDINE HYDROCHLORIDE

US Patent Number : 12042484

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216190

Patent Use Code : U-2779

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-05-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!